Pharmaceutical Technology's In the Lab eNewsletter, March 2023

Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.

The further we pursue CGT, the more variability we need to account for in order to engineer consistency into these new products.

Bio-Rad’s newly launched StarBright Blue and StarBright Yellow dyes are intended for use in various flow cytometry applications.

Eurofins Viracor ExPeCT CAR-T qPCR assay is a tool designed for monitoring and optimizating CAR-T therapies.

Moderna will leverage Life Edit’s suite of gene editing technologies to advance development of in vivo gene editing therapies.

AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.

The goal of this collaboration is to develop an approach to personalized radiotherapy and drug discovery that is based in genomics and artificial intelligence.

Quotient Sciences’ facility expansion is designed to increase support for fully integrated drug development programs.

The kit is meant for use for the detection and quantitation of residual host cell protein.

Thermo Fisher and Celltrio are introducing a new automation platform to address critical scale-up challenges in biotherapeutics.

iotaSciences isoPick is designed to expand handling solutions for cell biology and gene therapy applications.

Thermo Fisher’s sponsorship of Momentum Labs is intended to support biotech businesses in the greater Gainesville region.